Analysis for CBOE
- 📈 Growth — 26/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 17/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 4/10
Summary:
📈 Growth & Financial Trajectory
Over the 8 quarters, Revenues rose from about $0.97B to $1.44B, a cumulative gain of roughly 48%. Net income progressed from about $210M in 2024 Q1 to $353M in 2026 Q2, despite a dip in 2024 Q2, indicating improving profitability as volumes increased and mix shifted toward higher-margin segments.
💰 Margins & Cash Flow
Gross margins hovered in the mid-to-high 50% range in several quarters (notably 58% in some periods) with troughs near mid-40s; this supports robust operating leverage. Operating income generally tracked revenue, sustaining positive margins across the period. Cash flow: operating cash flow was strong in many quarters (positive), with investing outflows and financing activities shaping quarterly net cash flow; overall net cash flow was positive in multiple quarters.
🛡️ Balance Sheet & Liquidity
Assets consistently exceed liabilities; equity remains solid (roughly $4.0–4.5B across quarters). Long-term debt around $1.44B remains manageable, and current assets exceed current liabilities in most periods, implying liquidity resilience.
⚠️ Key Drivers & Risks
- Drivers: Market activity in core exchanges; data & analytics revenue growth
- Risks: Sensitivity to volatility cycles and regulatory shifts; valuation may be stretched if growth decelerates.